Cargando…

Cyclophosphamide versus cyclosporine A therapy in steroid-resistant nephrotic syndrome: a retrospective study with a mean 5-year follow-up

OBJECTIVE: To compare the clinical efficacy of cyclophosphamide (CTX) and cyclosporine A (CSA) in initial treatment of children with steroid-resistant nephrotic syndrome (SRNS). METHODS: Prospectively maintained databases were reviewed to retrospectively compare two cohorts with SRNS that received p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yanwei, Yang, Ruikun, Yang, Chen, Dong, Shuhong, Zhu, Ying, Zhao, Mingdong, Yuan, Fenglai, Gui, Keke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Clinical Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259365/ https://www.ncbi.nlm.nih.gov/pubmed/30185089 http://dx.doi.org/10.1177/0300060518782017

Ejemplares similares

Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study
por: Prasad, N., et al.
Publicado: (2018)

Cyclosporine A and steroid therapy in childhood steroid-resistant nephrotic syndrome
por: Tahar, Gargah, et al.
Publicado: (2010)

Beraprost sodium versus clopidogrel for preventing vascular thromboembolic events of arteriovenous fistula in uraemic patients: a retrospective study with a mean 3-year follow-up
por: Wan, Ziming, et al.
Publicado: (2018)

Treatment of Steroid and Cyclosporine-Resistant Idiopathic Nephrotic Syndrome in Children
por: Nikibakhsh, A. A., et al.
Publicado: (2011)

Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A Review
por: Shah, Syed Raza, et al.
Publicado: (2016)

A Randomized Controlled Trial of Intravenous versus Oral Cyclophosphamide in Steroid-resistant Nephrotic Syndrome in Children
por: Shah, K. M., et al.
Publicado: (2017)

Denosumab versus zoledronic acid for preventing symptomatic skeletal events in Asian postmenopausal women with oestrogen-receptor-positive advanced breast cancer: an outcome analyses with a mean follow-up of 3 years
por: Zhang, Chi, et al.
Publicado: (2018)

Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis
por: Li, Hong-Yan, et al.
Publicado: (2019)

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
por: Dorresteijn, Eiske M., et al.
Publicado: (2008)

Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria
por: Ladapo, Taiwo Augustina, et al.
Publicado: (2016)

The effectiveness of cyclosporine A for patients with steroid-resistant nephrotic syndrome: A protocol for systematic review and meta-analysis
por: Lv, Juan, et al.
Publicado: (2021)

Breastfeeding by a mother taking cyclosporine for nephrotic syndrome
por: Li, Ruizhe, et al.
Publicado: (2022)

Long-Term Follow-Up of Cyclical Cyclophosphamide and Steroids Versus Tacrolimus and Steroids in Primary Membranous Nephropathy
por: Ramachandran, Raja, et al.
Publicado: (2021)

Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial
por: Saito, Takao, et al.
Publicado: (2013)

First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome
por: Heekin, R. David, et al.
Publicado: (2019)

Pharmacokinetics of cyclosporin - a microemulsion in children with idiopathic nephrotic syndrome
por: dos Santos Henriques, Luciana, et al.
Publicado: (2012)

Cyclosporine A for the treatment of refractory nephrotic syndrome with renal dysfunction
por: GAO, XIANG, et al.
Publicado: (2014)

Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome
por: Iyengar, A., et al.
Publicado: (2013)

The level of transforming growth factor-β as a possible predictor of cyclophosphamide response in children with steroid-resistant nephrotic syndrome
por: Widiasta, Ahmedz, et al.
Publicado: (2021)

A Case of Frequently Relapsing Minimal-Change Nephrotic Syndrome with Steroid-Induced Psychiatric Syndrome Treated by Low-Dose, Short-Term Steroid Therapy in Combination with Cyclosporine
por: Kondo, Isao, et al.
Publicado: (2020)

Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease
por: Haddad, Maha, et al.
Publicado: (2021)

Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life
por: Wang, Li, et al.
Publicado: (2022)

Cyclosporine A – treated nephrotic children show impaired vasodilatation but no autonomic neuropathy
por: Czupryniak, Aneta, et al.
Publicado: (2010)

Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years
por: Kranz, Birgitta, et al.
Publicado: (2008)

Infliximab versus cyclosporine for severe ulcerative colitis refractory to steroids: A protocol for systematic review and meta-analysis
por: Wu, Dongjie, et al.
Publicado: (2018)

Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease
por: Gilman, Kristy E., et al.
Publicado: (2023)

Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety
por: Yu, Xiaojuan, et al.
Publicado: (2017)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
por: Hernani, Rafael, et al.
Publicado: (2021)

Prediction of steroid resistance and steroid dependence in nephrotic syndrome children
por: Zaorska, Katarzyna, et al.
Publicado: (2021)

Rhabdomyosarcoma in a child with nephrotic syndrome treated with cyclosporine: a case report with literature review
por: Wu, Huai-Chueh Gem, et al.
Publicado: (2020)

Urinary IgG and α2-Macroglobulin Are Powerful Predictors of Outcome and Responsiveness to Steroids and Cyclophosphamide in Idiopathic Focal Segmental Glomerulosclerosis with Nephrotic Syndrome
por: Bazzi, Claudio, et al.
Publicado: (2013)

B Lymphocyte Subsets in Children With Steroid-Sensitive Nephrotic Syndrome: A Longitudinal Study
por: Ling, Chen, et al.
Publicado: (2021)

Treatment of steroid-resistant pediatric nephrotic syndrome
por: Kang, Hee Gyung
Publicado: (2011)

Deflazacort in comparison to other steroids for nephrotic syndrome
por: Jat, K. R., et al.
Publicado: (2012)

Management of Steroid-Resistant Nephrotic Syndrome in Children
por: Sachdeva, Sanjana, et al.
Publicado: (2021)

Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
por: Sinha, Aditi, et al.
Publicado: (2021)

Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults
por: Fujiwara, Akira, et al.
Publicado: (2014)

Successful Treatment of Steroid-Dependent Eosinophilic Cellulitis With Cyclosporine
por: Kim, Su Hee, et al.
Publicado: (2013)

Refractory giardiasis in a child with steroid-resistant nephrotic syndrome
por: Kalita, Jitu Mani, et al.
Publicado: (2023)

Glomerular Filtration Rate Trends During Follow-up in Children With Steroid-Sensitive Nephrotic Syndrome
por: Alsaidi, Sulaiman, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b82rbdhaq2e0rg24ut9641ncu8